Comparison of the efficacy and safety of budesonide turbuhaler administered once daily with twice the dose of beclomethasone dipropionate using pressurised metered dose inhaler in patients with mild to moderate asthma

West African Journal of Medicine

Volumn 24, Issue 3, 2005, Pages 190-195

  Ohaju Obodo, J O ^a   Chukwu, C ^b   Okpapi, J ^c   Egbagbe, E ^d   Ige, M O ^e   Chukwuka, C ^f   Adedapo, D A ^g  

^a ASTRAZENECA   (United Kingdom)

^b LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^c AHMADU BELLO UNIVERSITY   (Nigeria)

^d UNIVERSITY OF BENIN   (Nigeria)

^e UNIVERSITY OF IBADAN   (Nigeria)

^f UNIVERSITY OF NIGERIA   (Nigeria)

^g UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Beclomethasone dipropionate; Bronchial asthma; Budesonide; Efficacy; Safety

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE;

ABDOMINAL DISEASE; ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SORE THROAT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; BUDESONIDE; DRUG TOXICITY; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METERED DOSE INHALERS; NIGERIA; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 28344449994     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Sofowora E O. Brochial asthma in the tropics: A study of 250 Nigerians patients East Afr Med J 1970; 47: 434-439.
2. Aderele W I. Bronchial asthma in Nigerian children Arch Dis child 1979; 54: 448-453.
3. Warell D A, Fawcett I W and Harrison BDW. Bronchial asthma in the Nigerian savannah region. A clinical and laboratory study of 106 patients with a review of the literature on asthma in the tropis Q J Med 1978; 44: 32-47.
4. Elegbeleye O O. Asthma death in Nigria Nig. Med. J 1978; 8: 449-451.
5. Haddock D R W. The pattern of bronchial asthma in Benin in the equatorial forest zone of Nigeria J Trop. Med. Hgy. 1977; 80: 204-212.
6. Awotedu A A, Wilson M G, Babalola O O. The catastrophic asthma attack: the experience at the University College Hospital Ibadan. Nig. Med. J 1994; 20: 19-22.
7. Action Asthma. The occurence and cost of asthma. Worthing, Cambridge Medical Publication 1990; 1: 1-12.
8. 2,-agonist in Asthma. Trends Pharmacol Sci. 1992; 13: 20-23.
9. 2,-agonists. AM J. Respir. Crit. Care Med 1994; 604-610.
10. Barnes P J, Petersen S. Efficacy and safety of inhaled glucocorticoids in asthma. Ann Rev. Respair Dis 1993; 148: 51-526.
11. Brambilla C. A comparative study of budesonide Turbuhaler and beclomethasone dipropionate pressurised metered dose inhaler in adult patients with ashma. Am. Rev Respir Dis 1992; 145: A737.
12. Agertoff L, Pederson S. Importance of the inhalation device on the effect of budesonide Ann Dis child 1993; 69: 130-3.
13. British Thoracic Society. British guidelines on asthma management. 1995 review and position statement. Thorax 1997; 52 (suppl. 1): S1-S21.
14. Guidelines for the diagnosis and treatment of asthma. Expert panel report 2. Clinical practice guidelines. Bethesda Md.: National Asthma Education Program. April 1997. (NIH publication no. 97-4051).
15. National institutes of health, National Heart, Lung and Blood Institute. Global initiative for asthma. Bethsda: National Heart, Lung and Blood Institute, National Institutes of Health. US Department of Health and Human services 1995; PN 95: 3659-78.
16. Nawhinney H, Spector S L, Kinsman R A, Siegel S C, Rachelefsky G S, Katz R M, Rohr A S. Compliance in clinical trials of two nonbronchodilator, antiasthma medications. Ann Allergy 1991; 66: 294-9.
17. Hom C R, Clark T J H, Cochrare G M. Compliance with inhaled therapy and morbidity from asthma. Respir. Med. 1990; 84: 67-70.
18. Boe J, Rosenhall L, Alton M. Comparison of dose response effects of inhaled beclometasone dipropionate and budesonide in the management of asthma. Allergy. 1989; 44: 349-355.
19. Keelan P, Cray P, Kelly P, From M. Comparison of a new corticosteroid aerosol budesonide, with beclomethaasone dipropionate in the treatment of chronic asthma mt. Med. J. 1984; 77: 244-247.
20. Selroos O, Pietinalho A, Riska H. Delivery devices for inhaled asthma medication. Clinical implications of differences in effectiveness. Clin. Immunother. 1996; 6: 273-99.
21. Moller C, Stromberg L, Oldaeus G, Arwestrom E, Kjellman M. Administration of budesonide via Turbuhaler® (200-tg and 400p-g) once daily is as effective as when given twice daily in children with asthma. Eur Respir. J. 1996; 9(Suppl 23): 1155.
22. Pauwels R A, Hargreave F E, Camus P, Bukoski M, Sahl E. A 1-year comparison of Turbuhaler Vs pressurized metered dose inhaler in asthmatic patients. Chest 1996; 110: 53-7.
23. 4 receptor antagonist in subjects with bronchial asthma. Am J. Respir. Crit care Meds. 1994; 150: 52 1-527.
24. Brogden R N, McTavish D. Budesonide An updated review of its pharmacological properties and therapeutic efficacy in asthma and rhinitis. Drugs 1992; 44: 375-407.
25. Thorsson L, Edsbacker 5, Conradson T. Lung deposition of budesonide is twice that from a pressurised metered dose inhaler. Thorax. 1993; 48.48: 434.
26. Piguet J, Zuck P, Dennewald G. The French budesonide Trial group: Equal efficacious asthma management iwht budesonide 800p-g administered by Turbuhaler® or with Beclomethasone dipropionate > 1500-tg given through a pMDI with spacer, advances in Therapy 1996; 13: 38-50.
27. Agertofi L, Pederson S. Importance of the inhalation device on the effect of budesonide Arch Dis child 1993; 69: 130-133.
28. Agertofi U, Pederson S. Effect of long term treatment with an inhaled corticosteriods on growth and pulmonary function in asthma children. Resp. N4ed 1994; 88: 373-381.
29. Brambilla C, Godard P, Lacronique J. A 3-month comparative dose reduction study with inhaled beclomethasone dipropionate and budesonide in the management of moderate-to-severe-asthma. Drug invest. 1994; 8.1: 49-56.